Johnson & Johnson submits emergency use listing to WHO for Covid-19 vaccine

Johnson & Johnson submits emergency use listing to WHO for Covid-19 vaccine
Johnson & Johnson submits emergency use listing to WHO for Covid-19 vaccine

Hello and welcome to the details of Johnson & Johnson submits emergency use listing to WHO for Covid-19 vaccine and now with the details

Nevin Al Sukari - Sana'a - The company said the process is a prerequisite to supply vaccines to the Covax vaccine program co-led by WHO. — Reuters pic

Subscribe to our Telegram channel for the latest updates on news you need to know.


NEW YORK, Feb 19 — Johnson & Johnson said today it had submitted for emergency use listing of its Covid-19 vaccine to the World Health Organisation (WHO).

The company said the process is a prerequisite to supply vaccines to the Covax vaccine program co-led by WHO, which aims to deliver doses to poor and middle-income countries.

J&J entered into an agreement in December in support of the Covax program.

The company and Gavi, which also co-leads the Covax program, expect to enter into an advance purchase agreement that would provide up to 500 million doses of the single-dose vaccine to Covax through 2022, J&J said. — Reuters

These were the details of the news Johnson & Johnson submits emergency use listing to WHO for Covid-19 vaccine for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

NEXT India's lauds Gulf assistance in fighting COVID-19